Page 101 - SAMRC Annual Report 2023-24
P. 101

PERFORMANCE INFORMATION








                                                               Cochrane
                                                               South Africa






                                                               Deputy Director:
                                                               Dr. Duduzile Ndwandwe







            Prioritising responsive research                   and resources to reach a broader audience and have
            through impactful interventions                    a greater impact.

            During  the  2023/24  financial  year,  our  main  goal   Overall, these initiatives were instrumental in
            during this period was to launch the GloPID-R Africa   empowering both our staff and the community,
            hub. This initiative aimed to ensure coordinated   thereby promoting equity and dignity in health
            funding for pandemic preparedness in Africa. By    research and healthcare.
            addressing the critical issue of funding coordination,
            the GloPID-R Africa hub seeks to enhance Africa's   Science for creating a
            ability to respond effectively to pandemics. Despite   healthier society
            the challenges faced, we successfully launched the
            hub on in August 2023, laying the groundwork for   Cochrane South Africa actively engaged in offering
            improved pandemic preparedness and response        knowledge translation and evidence-informed
            across the continent.                              decision-making workshops with special focus
                                                               on historically disadvantaged institutions like the
            Equitable capacity development                     University of Venda, University of Zululand and
            for empowering communities                         University of the Western Cape, taking our science
                                                               and research out of the laboratory and into the
            Throughout  the  2023/24  financial  year,  Cochrane   community.
            South  Africa  prioritised  capacity  development
            initiatives aimed at empowering both our staff and   Feedback from these engagements has been
            the broader community, with a focus on promoting   overwhelmingly positive, with appreciation for
            equity and dignity in health research and healthcare.   the opportunity to learn about evidence-based
            We organised regular training sessions and         healthcare and research methodologies. Participants
            workshops to enhance the skills and expertise of our   have reported feeling empowered to make informed
            staff members, covering various aspects of health   decisions about their health and have expressed a
            research methodology, evidence synthesis, and      keen interest in further engagement with our team.
            systematic review processes.                       Additionally, these interactions have provided
                                                               valuable insights into the health needs and priorities
            Within our unit, we promoted diversity and         of the community, helping to guide our research
            inclusivity, ensuring that all staff members had equal   efforts and ensure that they are aligned with the
            opportunities for professional development and     needs of the populations we serve.
            advancement. Moreover, we fostered partnerships
            and collaborations with various organisations and   Overall, these engagements have been instrumental
            institutions such as Oxford University, COMET      in bridging the gap between research and those who
            Initiative to name a few, to expand our capacity   need information, ultimately promoting evidence-
            development initiatives, leveraging their expertise   based healthcare and improving health outcomes.





                                                              SAMRC  ANNUAL REPOR T 2023-24               99
   96   97   98   99   100   101   102   103   104   105   106